Tag: Phase III

Novartis’ MS Treatment Met Endpoints in Two Studies

Novartis’ ofatumumab (OMB157) has achieved the primary endpoints in two phase III trials of relapsing multiple sclerosis (MS). The data from ASCLEPIOS I and II studies has demonstrated that ofatumu...

Bayer Clinical Study of Tropical Disease Treatment Met Endpoint

Largest clinical treatment study to date in pediatric patients with Chagas disease. Bayer today presented the results of the CHICO (CHagas disease In Children treated with NifurtimOx) phase III cli...

NeuroBo to Initiate Phase III Trial for its Lead Drug

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases announced its plans to initiate a Phase III trial to ...